Global Nanomedicine Market Research Report 2022
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanomedicine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Quantum dots
1.2.3 Nanoparticles
1.2.4 Nanoshells
1.2.5 Nanotubes
1.2.6 Nanodevices
1.3 Market by Application
1.3.1 Global Nanomedicine Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 oncology
1.3.3 Infectious diseases
1.3.4 Cardiology
1.3.5 Orthopedics
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nanomedicine Market Perspective (2017-2028)
2.2 Nanomedicine Growth Trends by Region
2.2.1 Nanomedicine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nanomedicine Historic Market Size by Region (2017-2022)
2.2.3 Nanomedicine Forecasted Market Size by Region (2023-2028)
2.3 Nanomedicine Market Dynamics
2.3.1 Nanomedicine Industry Trends
2.3.2 Nanomedicine Market Drivers
2.3.3 Nanomedicine Market Challenges
2.3.4 Nanomedicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanomedicine Players by Revenue
3.1.1 Global Top Nanomedicine Players by Revenue (2017-2022)
3.1.2 Global Nanomedicine Revenue Market Share by Players (2017-2022)
3.2 Global Nanomedicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nanomedicine Revenue
3.4 Global Nanomedicine Market Concentration Ratio
3.4.1 Global Nanomedicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanomedicine Revenue in 2021
3.5 Nanomedicine Key Players Head office and Area Served
3.6 Key Players Nanomedicine Product Solution and Service
3.7 Date of Enter into Nanomedicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanomedicine Breakdown Data by Type
4.1 Global Nanomedicine Historic Market Size by Type (2017-2022)
4.2 Global Nanomedicine Forecasted Market Size by Type (2023-2028)
5 Nanomedicine Breakdown Data by Application
5.1 Global Nanomedicine Historic Market Size by Application (2017-2022)
5.2 Global Nanomedicine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nanomedicine Market Size (2017-2028)
6.2 North America Nanomedicine Market Size by Country (2017-2022)
6.3 North America Nanomedicine Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Nanomedicine Market Size (2017-2028)
7.2 Europe Nanomedicine Market Size by Country (2017-2022)
7.3 Europe Nanomedicine Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanomedicine Market Size (2017-2028)
8.2 Asia-Pacific Nanomedicine Market Size by Country (2017-2022)
8.3 Asia-Pacific Nanomedicine Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Nanomedicine Market Size (2017-2028)
9.2 Latin America Nanomedicine Market Size by Country (2017-2022)
9.3 Latin America Nanomedicine Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanomedicine Market Size (2017-2028)
10.2 Middle East & Africa Nanomedicine Market Size by Country (2017-2022)
10.3 Middle East & Africa Nanomedicine Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Combimatrix
11.1.1 Combimatrix Company Detail
11.1.2 Combimatrix Business Overview
11.1.3 Combimatrix Nanomedicine Introduction
11.1.4 Combimatrix Revenue in Nanomedicine Business (2017-2022)
11.1.5 Combimatrix Recent Development
11.2 Ablynx
11.2.1 Ablynx Company Detail
11.2.2 Ablynx Business Overview
11.2.3 Ablynx Nanomedicine Introduction
11.2.4 Ablynx Revenue in Nanomedicine Business (2017-2022)
11.2.5 Ablynx Recent Development
11.3 Abraxis Bioscience
11.3.1 Abraxis Bioscience Company Detail
11.3.2 Abraxis Bioscience Business Overview
11.3.3 Abraxis Bioscience Nanomedicine Introduction
11.3.4 Abraxis Bioscience Revenue in Nanomedicine Business (2017-2022)
11.3.5 Abraxis Bioscience Recent Development
11.4 Celgene
11.4.1 Celgene Company Detail
11.4.2 Celgene Business Overview
11.4.3 Celgene Nanomedicine Introduction
11.4.4 Celgene Revenue in Nanomedicine Business (2017-2022)
11.4.5 Celgene Recent Development
11.5 Mallinckrodt
11.5.1 Mallinckrodt Company Detail
11.5.2 Mallinckrodt Business Overview
11.5.3 Mallinckrodt Nanomedicine Introduction
11.5.4 Mallinckrodt Revenue in Nanomedicine Business (2017-2022)
11.5.5 Mallinckrodt Recent Development
11.6 Arrowhead Research
11.6.1 Arrowhead Research Company Detail
11.6.2 Arrowhead Research Business Overview
11.6.3 Arrowhead Research Nanomedicine Introduction
11.6.4 Arrowhead Research Revenue in Nanomedicine Business (2017-2022)
11.6.5 Arrowhead Research Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Detail
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Nanomedicine Introduction
11.7.4 GE Healthcare Revenue in Nanomedicine Business (2017-2022)
11.7.5 GE Healthcare Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Nanomedicine Introduction
11.8.4 Merck Revenue in Nanomedicine Business (2017-2022)
11.8.5 Merck Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Nanomedicine Introduction
11.9.4 Pfizer Revenue in Nanomedicine Business (2017-2022)
11.9.5 Pfizer Recent Development
11.10 Nanosphere
11.10.1 Nanosphere Company Detail
11.10.2 Nanosphere Business Overview
11.10.3 Nanosphere Nanomedicine Introduction
11.10.4 Nanosphere Revenue in Nanomedicine Business (2017-2022)
11.10.5 Nanosphere Recent Development
11.11 Epeius Biotechnologies
11.11.1 Epeius Biotechnologies Company Detail
11.11.2 Epeius Biotechnologies Business Overview
11.11.3 Epeius Biotechnologies Nanomedicine Introduction
11.11.4 Epeius Biotechnologies Revenue in Nanomedicine Business (2017-2022)
11.11.5 Epeius Biotechnologies Recent Development
11.12 Cytimmune Sciences
11.12.1 Cytimmune Sciences Company Detail
11.12.2 Cytimmune Sciences Business Overview
11.12.3 Cytimmune Sciences Nanomedicine Introduction
11.12.4 Cytimmune Sciences Revenue in Nanomedicine Business (2017-2022)
11.12.5 Cytimmune Sciences Recent Development
11.13 Nanospectra Biosciences
11.13.1 Nanospectra Biosciences Company Detail
11.13.2 Nanospectra Biosciences Business Overview
11.13.3 Nanospectra Biosciences Nanomedicine Introduction
11.13.4 Nanospectra Biosciences Revenue in Nanomedicine Business (2017-2022)
11.13.5 Nanospectra Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Nanomedicine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Quantum dots
Table 3. Key Players of Nanoparticles
Table 4. Key Players of Nanoshells
Table 5. Key Players of Nanotubes
Table 6. Key Players of Nanodevices
Table 7. Global Nanomedicine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Nanomedicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Nanomedicine Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Nanomedicine Market Share by Region (2017-2022)
Table 11. Global Nanomedicine Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Nanomedicine Market Share by Region (2023-2028)
Table 13. Nanomedicine Market Trends
Table 14. Nanomedicine Market Drivers
Table 15. Nanomedicine Market Challenges
Table 16. Nanomedicine Market Restraints
Table 17. Global Nanomedicine Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Nanomedicine Market Share by Players (2017-2022)
Table 19. Global Top Nanomedicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicine as of 2021)
Table 20. Ranking of Global Top Nanomedicine Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Nanomedicine Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nanomedicine Product Solution and Service
Table 24. Date of Enter into Nanomedicine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nanomedicine Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Nanomedicine Revenue Market Share by Type (2017-2022)
Table 28. Global Nanomedicine Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Nanomedicine Revenue Market Share by Type (2023-2028)
Table 30. Global Nanomedicine Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Nanomedicine Revenue Market Share by Application (2017-2022)
Table 32. Global Nanomedicine Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Nanomedicine Revenue Market Share by Application (2023-2028)
Table 34. North America Nanomedicine Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Nanomedicine Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Nanomedicine Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Nanomedicine Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Nanomedicine Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Nanomedicine Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Nanomedicine Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Nanomedicine Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Nanomedicine Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Nanomedicine Market Size by Country (2023-2028) & (US$ Million)
Table 44. Combimatrix Company Detail
Table 45. Combimatrix Business Overview
Table 46. Combimatrix Nanomedicine Product
Table 47. Combimatrix Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
Table 48. Combimatrix Recent Development
Table 49. Ablynx Company Detail
Table 50. Ablynx Business Overview
Table 51. Ablynx Nanomedicine Product
Table 52. Ablynx Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
Table 53. Ablynx Recent Development
Table 54. Abraxis Bioscience Company Detail
Table 55. Abraxis Bioscience Business Overview
Table 56. Abraxis Bioscience Nanomedicine Product
Table 57. Abraxis Bioscience Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
Table 58. Abraxis Bioscience Recent Development
Table 59. Celgene Company Detail
Table 60. Celgene Business Overview
Table 61. Celgene Nanomedicine Product
Table 62. Celgene Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
Table 63. Celgene Recent Development
Table 64. Mallinckrodt Company Detail
Table 65. Mallinckrodt Business Overview
Table 66. Mallinckrodt Nanomedicine Product
Table 67. Mallinckrodt Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
Table 68. Mallinckrodt Recent Development
Table 69. Arrowhead Research Company Detail
Table 70. Arrowhead Research Business Overview
Table 71. Arrowhead Research Nanomedicine Product
Table 72. Arrowhead Research Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
Table 73. Arrowhead Research Recent Development
Table 74. GE Healthcare Company Detail
Table 75. GE Healthcare Business Overview
Table 76. GE Healthcare Nanomedicine Product
Table 77. GE Healthcare Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
Table 78. GE Healthcare Recent Development
Table 79. Merck Company Detail
Table 80. Merck Business Overview
Table 81. Merck Nanomedicine Product
Table 82. Merck Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
Table 83. Merck Recent Development
Table 84. Pfizer Company Detail
Table 85. Pfizer Business Overview
Table 86. Pfizer Nanomedicine Product
Table 87. Pfizer Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
Table 88. Pfizer Recent Development
Table 89. Nanosphere Company Detail
Table 90. Nanosphere Business Overview
Table 91. Nanosphere Nanomedicine Product
Table 92. Nanosphere Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
Table 93. Nanosphere Recent Development
Table 94. Epeius Biotechnologies Company Detail
Table 95. Epeius Biotechnologies Business Overview
Table 96. Epeius Biotechnologies NanomedicineProduct
Table 97. Epeius Biotechnologies Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
Table 98. Epeius Biotechnologies Recent Development
Table 99. Cytimmune Sciences Company Detail
Table 100. Cytimmune Sciences Business Overview
Table 101. Cytimmune Sciences NanomedicineProduct
Table 102. Cytimmune Sciences Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
Table 103. Cytimmune Sciences Recent Development
Table 104. Nanospectra Biosciences Company Detail
Table 105. Nanospectra Biosciences Business Overview
Table 106. Nanospectra Biosciences NanomedicineProduct
Table 107. Nanospectra Biosciences Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
Table 108. Nanospectra Biosciences Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Nanomedicine Market Share by Type: 2021 VS 2028
Figure 2. Quantum dots Features
Figure 3. Nanoparticles Features
Figure 4. Nanoshells Features
Figure 5. Nanotubes Features
Figure 6. Nanodevices Features
Figure 7. Global Nanomedicine Market Share by Application in 2021 & 2028
Figure 8. oncology Case Studies
Figure 9. Infectious diseases Case Studies
Figure 10. Cardiology Case Studies
Figure 11. Orthopedics Case Studies
Figure 12. Others Case Studies
Figure 13. Nanomedicine Report Years Considered
Figure 14. Global Nanomedicine Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Nanomedicine Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Nanomedicine Market Share by Region: 2021 VS 2028
Figure 17. Global Nanomedicine Market Share by Players in 2021
Figure 18. Global Top Nanomedicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicine as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Nanomedicine Revenue in 2021
Figure 20. North America Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. North America Nanomedicine Market Share by Country (2017-2028)
Figure 22. United States Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Nanomedicine Market Share by Country (2017-2028)
Figure 26. Germany Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Nanomedicine Market Share by Region (2017-2028)
Figure 34. China Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Nanomedicine Market Share by Country (2017-2028)
Figure 42. Mexico Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Brazil Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Nanomedicine Market Share by Country (2017-2028)
Figure 46. Turkey Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Saudi Arabia Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Combimatrix Revenue Growth Rate in Nanomedicine Business (2017-2022)
Figure 49. Ablynx Revenue Growth Rate in Nanomedicine Business (2017-2022)
Figure 50. Abraxis Bioscience Revenue Growth Rate in Nanomedicine Business (2017-2022)
Figure 51. Celgene Revenue Growth Rate in Nanomedicine Business (2017-2022)
Figure 52. Mallinckrodt Revenue Growth Rate in Nanomedicine Business (2017-2022)
Figure 53. Arrowhead Research Revenue Growth Rate in Nanomedicine Business (2017-2022)
Figure 54. GE Healthcare Revenue Growth Rate in Nanomedicine Business (2017-2022)
Figure 55. Merck Revenue Growth Rate in Nanomedicine Business (2017-2022)
Figure 56. Pfizer Revenue Growth Rate in Nanomedicine Business (2017-2022)
Figure 57. Nanosphere Revenue Growth Rate in Nanomedicine Business (2017-2022)
Figure 58. Epeius Biotechnologies Revenue Growth Rate in Nanomedicine Business (2017-2022)
Figure 59. Cytimmune Sciences Revenue Growth Rate in Nanomedicine Business (2017-2022)
Figure 60. Nanospectra Biosciences Revenue Growth Rate in Nanomedicine Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed